FUCALES DA
Closed at July 13th, 2023
Keywords
researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors
Organization
- CEO
- WY
Wenche Ytreland1968
- Operation time
- 5 years
- - Jun 5, 2018 to Jul 13, 2023
- Type
- General Partnership with shared liability
- VAT registered
- No
- Number of employees
- 0
Last update: Apr 13, 2023
Management
Management / administration
Name | Role | Shares |
---|---|---|
WY 1968 | Managing Director/CEO | - |
Board
Name | Role | Shares |
---|---|---|
SV 1969 | Participant with Pro Rata Liability (Shared Liability) | - |
WY 1968 | Participant with Pro Rata Liability (Shared Liability) | - |
Last update: Apr 13, 2023
Ownership
No available data
Financials
in NOK
No available data
Classification
Type of organization
General Partnership with shared liability
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2300
Private non-financial unincorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology